Literature DB >> 28707484

Autoregressive Modeling of Drift and Random Error to Characterize a Continuous Intravascular Glucose Monitoring Sensor.

Tony Zhou1, Jennifer L Dickson1, J Geoffrey Chase1.   

Abstract

BACKGROUND: Continuous glucose monitoring (CGM) devices have been effective in managing diabetes and offer potential benefits for use in the intensive care unit (ICU). Use of CGM devices in the ICU has been limited, primarily due to the higher point accuracy errors over currently used traditional intermittent blood glucose (BG) measures. General models of CGM errors, including drift and random errors, are lacking, but would enable better design of protocols to utilize these devices. This article presents an autoregressive (AR) based modeling method that separately characterizes the drift and random noise of the GlySure CGM sensor (GlySure Limited, Oxfordshire, UK).
METHODS: Clinical sensor data (n = 33) and reference measurements were used to generate 2 AR models to describe sensor drift and noise. These models were used to generate 100 Monte Carlo simulations based on reference blood glucose measurements. These were then compared to the original CGM clinical data using mean absolute relative difference (MARD) and a Trend Compass.
RESULTS: The point accuracy MARD was very similar between simulated and clinical data (9.6% vs 9.9%). A Trend Compass was used to assess trend accuracy, and found simulated and clinical sensor profiles were similar (simulated trend index 11.4° vs clinical trend index 10.9°).
CONCLUSION: The model and method accurately represents cohort sensor behavior over patients, providing a general modeling approach to any such sensor by separately characterizing each type of error that can arise in the data. Overall, it enables better protocol design based on accurate expected CGM sensor behavior, as well as enabling the analysis of what level of each type of sensor error would be necessary to obtain desired glycemic control safety and performance with a given protocol.

Entities:  

Keywords:  blood glucose; continuous glucose monitoring; modeling; sensor; simulation

Mesh:

Substances:

Year:  2017        PMID: 28707484      PMCID: PMC5761979          DOI: 10.1177/1932296817719089

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  50 in total

Review 1.  Tight glycemic control in critical care--the leading role of insulin sensitivity and patient variability: a review and model-based analysis.

Authors:  J Geoffrey Chase; Aaron J Le Compte; Fatanah Suhaimi; Geoffrey M Shaw; Adrienne Lynn; Jessica Lin; Christopher G Pretty; Normy Razak; Jacquelyn D Parente; Christopher E Hann; Jean-Charles Preiser; Thomas Desaive
Journal:  Comput Methods Programs Biomed       Date:  2010-12-09       Impact factor: 5.428

2.  A dual-rate Kalman filter for continuous glucose monitoring.

Authors:  Matthew Kuure-Kinsey; Cesar C Palerm; B Wayne Bequette
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006

3.  Accuracy of a new real-time continuous glucose monitoring algorithm.

Authors:  D Barry Keenan; Raymond Cartaya; John J Mastrototaro
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

Review 4.  Alterations in fuel metabolism in critical illness: hyperglycaemia.

Authors:  B A Mizock
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-12       Impact factor: 4.690

Review 5.  Glucose Control in the ICU: A Continuing Story.

Authors:  Jean-Charles Preiser; J Geoffrey Chase; Roman Hovorka; Jeffrey I Joseph; James S Krinsley; Christophe De Block; Thomas Desaive; Luc Foubert; Pierre Kalfon; Ulrike Pielmeier; Tom Van Herpe; Jan Wernerman
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

6.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

7.  Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Robin J Larson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

8.  Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control.

Authors:  Christopher G Pretty; Aaron J Le Compte; J Geoffrey Chase; Geoffrey M Shaw; Jean-Charles Preiser; Sophie Penning; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2012-06-15       Impact factor: 6.925

9.  The impact of early hypoglycemia and blood glucose variability on outcome in critical illness.

Authors:  Sean M Bagshaw; Rinaldo Bellomo; Michael J Jacka; Moritoki Egi; Graeme K Hart; Carol George
Journal:  Crit Care       Date:  2009-06-17       Impact factor: 9.097

10.  Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial.

Authors:  Ulrike Holzinger; Joanna Warszawska; Reinhard Kitzberger; Marlene Wewalka; Wolfgang Miehsler; Harald Herkner; Christian Madl
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

View more
  3 in total

1.  Continuous Glucose Monitoring Measures Can Be Used for Glycemic Control in the ICU: An In-Silico Study.

Authors:  Tony Zhou; Jennifer L Dickson; Geoffrey M Shaw; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2017-11-06

Review 2.  Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them.

Authors:  J Geoffrey Chase; Jean-Charles Preiser; Jennifer L Dickson; Antoine Pironet; Yeong Shiong Chiew; Christopher G Pretty; Geoffrey M Shaw; Balazs Benyo; Knut Moeller; Soroush Safaei; Merryn Tawhai; Peter Hunter; Thomas Desaive
Journal:  Biomed Eng Online       Date:  2018-02-20       Impact factor: 2.819

Review 3.  Representation Learning for Fine-Grained Change Detection.

Authors:  Niall O'Mahony; Sean Campbell; Lenka Krpalkova; Anderson Carvalho; Joseph Walsh; Daniel Riordan
Journal:  Sensors (Basel)       Date:  2021-06-30       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.